People: Novartis AG (NVS)
74.15USD
17 May 2013
$-0.86 (-1.15%)
$75.01
$73.53
$74.16
$73.50
1,092,063
1,584,517
$75.67
$51.20
Fishman, Mark
Brief Biography
Dr. Mark C. Fishman, M.D., has served as Member of the Executive Committee and President of Novartis Institute for BioMedical Research (NIBR) at Novartis AG since 2002. Before joining Novartis in 2002, Dr. Fishman was Chief of Cardiology and Director of the Cardiovascular Research Center at Massachusetts General Hospital, and Professor of Medicine at Harvard Medical School, both in the United States. Dr. Fishman has worked with national policy and scientific committees, including those of the United States National Institutes of Health (NIH) and the Wellcome Trust. He completed his internal medicine residency, chief residency and cardiology training at Massachusetts General Hospital. Dr. Fishman graduated with a bachelors degree from Yale College in 1972 and a Doctorate of Medicine (M.D.) from Harvard Medical School in 1976. He has been honored with awards and distinguished lectureships, and is Member of the Institute of Medicine of the National Academies (the United States) and a Fellow of the American Academy of Arts and Sciences.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 1,980,000 | 5,507,070 | 361,151 | 7,848,220 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Daniel Vasella |
13,067,600 |
Joseph Jimenez |
13,228,200 |
Ulrich Lehner |
853,107 |
Jonathan Symonds |
4,646,210 |
Felix Ehrat |
3,584,790 |
Juergen Brokatzky-Geiger |
3,474,440 |

